Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Carcas

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|November 6, 2009
A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patientsE Ramirez, A J Carcas, A M Borobia, et al.
European Journal of Clinical Pharmacology|May 22, 2008
The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studiesE Ramirez, P Guerra, O Laosa, et al.
Arzneimittel-Forschung|April 1, 1997
Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 daysJ Frías, C Esteban, A J Carcas, et al.
Journal of Clinical Pharmacology|August 1, 1996
Evaluation of sex differences in the pharmacokinetics of ranitidine in humansF Abad-Santos, A J Carcas, P Guerra, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 18, 1998
Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteersI Galicia, J Frias-Iniesta, A J Carcas, et al.
The Pharmacogenomics Journal|January 18, 2017
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplantG N Almeida-Paulo, I Dapía García, R Lubomirov, et al.
Revista Clinica Espanola|March 10, 2009
[Risk of thromboembolic events and evaluation of the use of venous thromboembolism prophylaxis in hospitalized medical patients and after discharge]A M Borobia, C Fernández Capitán, N Iniesta Arandia, et al.
Drug Research|February 22, 2013
A preliminary model to avoid the overestimation of sample size in bioequivalence studiesE Ramírez, V Abraira, P Guerra, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 2, 2011
Use of antifungal agents in pediatric and adult high-risk areasE Ramírez, J García-Rodríguez, A M Borobia, et al.
Infection|November 10, 2000
Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trialA J Torres, L D Valladares, J M Jover, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|November 6, 2009
A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patientsE Ramirez, A J Carcas, A M Borobia, et al.
European Journal of Clinical Pharmacology|May 22, 2008
The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studiesE Ramirez, P Guerra, O Laosa, et al.
Arzneimittel-Forschung|April 1, 1997
Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 daysJ Frías, C Esteban, A J Carcas, et al.
Journal of Clinical Pharmacology|August 1, 1996
Evaluation of sex differences in the pharmacokinetics of ranitidine in humansF Abad-Santos, A J Carcas, P Guerra, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 18, 1998
Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteersI Galicia, J Frias-Iniesta, A J Carcas, et al.
The Pharmacogenomics Journal|January 18, 2017
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplantG N Almeida-Paulo, I Dapía García, R Lubomirov, et al.
Revista Clinica Espanola|March 10, 2009
[Risk of thromboembolic events and evaluation of the use of venous thromboembolism prophylaxis in hospitalized medical patients and after discharge]A M Borobia, C Fernández Capitán, N Iniesta Arandia, et al.
Drug Research|February 22, 2013
A preliminary model to avoid the overestimation of sample size in bioequivalence studiesE Ramírez, V Abraira, P Guerra, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 2, 2011
Use of antifungal agents in pediatric and adult high-risk areasE Ramírez, J García-Rodríguez, A M Borobia, et al.
Infection|November 10, 2000
Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trialA J Torres, L D Valladares, J M Jover, et al.
Pageof 3